Madhav Thambisetty, M.D.

Associated Investigator
E-mail: thambisettym@mail.nih.gov

Publications

Roberts J, Varma V, Candia J, Tanaka T, Ferucci L, Bennett D, Thambisetty M. Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS and NTN1 in an Alzheimer’s disease brain proteomic signature. NPI Aging, 2023; 9: 18.
Desai RJ, Varma VR, Gerhard T, Segal J, Mahesri M, Chin K, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. Comparative risk of Alzheimer disease and related dementia among medicare beneficiaries with rheumatoid arthritis treated with targeted disease-modifying antirheumatic agents. JAMA Netw Open. 2022;5:e226567.
Varma VR, Büşra Lüleci H, Oommen AM, Varma S, Blackshear CT, Griswold ME, An Y, Roberts JA, O’Brien R, Pletnikova O, Troncoso JC, Bennett DA, Çakir T, Legido-Quigley C, Thambisetty M. Abnormal brain cholesterol homeostasis in Alzheimer’s disease – a targeted metabolic and transcriptomic study. NPJ Aging Mech Dis. 2021; 7:11.
Varma V, Oommen A, Varma S, Casanova R, An Y, Andrews R, O’Brien R, Pletnikova O, Troncoso J, Toledo J, Baillie R, Arnold M, Kastenmueller G, Nho K, Doraiswamy P, Saykin A, Kaddurah-Daouk R, Legido-Quigley C, Thambisett M. Brain and blood metabolite signatures of pathology and progression in Alzheimer’s disease: A targeted metabolomics study. PLoS Med 2018; 15: e1002482.

Director, Unit of Clinical & Translational Neuroscience, NIA